A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (NCT05595642)

🧪 Interventions in This Study

• Astegolimab (DRUG)
• Placebo (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (382 Sites)

Showing the first 25 of 382 sites.

• University of Alabama at Birmingham — Birmingham, Alabama
• SEC Clinical Research LLC - Dothan 2 - ClinEdge - PPDS — Dothan, Alabama
• Pulmonary Associates PA — Glendale, Arizona
• AES - DRS - Synexus Clinical Research US, Inc. - Tucson — Tucson, Arizona
• Kern Research — Bakersfield, California
• Allergy & Asthma Medical Group of the Bay Area — Walnut Creek, California
• Finlay Medical Research Corporation — Greenacres City, Florida
• San Marcus Research Clinic Inc. — Miami, Florida
• Oceane7 Medical & Research Center, Inc. — Miami, Florida
• Avantis Clinical Research, LLC — Miami, Florida
• Research Institute of South Florida Inc — Miami, Florida
• Diverse Clinical Research, LLC — Miami, Florida
• Central Florida Pulmonary Group, PA — Orlando, Florida
• AES - DRS - Synexus Clinical Research US, Inc. - The Villages — The Villages, Florida
• AES - DRS - Synexus Clinical Research US, Inc. - Atlanta — Atlanta, Georgia
• Allergy Center at Brookstone Research - Centricity Research - HyperCore - PPD — Columbus, Georgia
• Pivotal Research Solutions — Stonecrest, Georgia
• ASHA Clinical Research - ClinEdge - PPDS — Hammond, Indiana
• The Research Group of Lexington, LLC — Lexington, Kentucky
• Best Clinical Trials — New Orleans, Louisiana
• Paul A. Shapero, MD, PA — Bangor, Maine
• Pulmonary Research Institute of Southeast Michigan — Farmington Hills, Michigan
• Flushing Road Internal Medicine and Pediatrics - F — Flint, Michigan
• Revive Research Institute — Lathrup Village, Michigan
• Oakland Medical Research Center — Troy, Michigan

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Chronic Obstructive Pulmonary Disease (COPD)

• Laying the Foundation for Building a Resilient KPNC Community in the Face of Worsening Air Quality Due to Wildfire Smoke — Pleasanton, California
• WearME-Pro Phase II: Remote Use Usability and Longitudinal Validation Study (Patch Form Factor). — Baltimore, Maryland
• Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations — Durham, North Carolina
• Multi-Center Clean Air Randomized Controlled Trial in COPD — Birmingham, Alabama
• To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment — Phoenix, Arizona

Explore by condition: All Chronic Obstructive Pulmonary Disease (COPD) clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.